Sweden Faces Criticism Over New COVID-19 Vaccination Strategy
Sweden Alters Vaccine Policy for Autumn Rollout
Sweden has introduced a revised COVID-19 vaccination strategy for the autumn season, setting it apart from many of its European neighbors. The Swedish Public Health Agency is now offering free vaccinations only to people aged 75 and older, as well as medically vulnerable individuals aged 18–74. However, healthy individuals aged 65–74—approximately 820,000 people—are not included in the recommendation unless regional authorities have already vaccinated all higher-priority groups.
Medical Experts Raise Concerns
The decision has sparked debate among health professionals. Critics argue that raising the age threshold lacks medical justification. Åke Lundkvist, a virologist at Uppsala University, emphasized that immune function begins to decline after the age of 50 and suggested that all individuals over 60 should be encouraged to receive the vaccine. The Public Health Agency defends its decision, citing reduced risks due to widespread immunity and the milder nature of current virus variants.
Economic Considerations Behind the Policy
The new guidelines are based on a health economic analysis that found limited benefits in vaccinating healthy individuals over 65. Ulrika Marking, an infectious disease expert at the agency, stated that the economic gain from vaccinating this group is minimal. However, critics argue the analysis fails to consider the long-term costs of post-COVID conditions. An internal report also admits that reaching all vulnerable individuals aged 65–79 may be difficult, potentially increasing the disease burden.
Nordic and European Responses Vary
Sweden’s approach contrasts with that of neighboring Denmark, where all individuals aged 65 and above are still encouraged to get vaccinated. Danish authorities cite recent hospitalization and mortality data to justify their inclusive policy, while warning that future virus mutations could reverse current trends.
Other countries such as France, Belgium, and the Netherlands continue to recommend vaccines for those aged 60–65 and older. Meanwhile, the UK, Norway, and Finland have adopted policies similar to Sweden's. The European Centre for Disease Prevention and Control (ECDC) declined to comment on the diverging national strategies.